Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols.

Ribera, Jordi; Granada, Isabel; Morgades, Mireia; González, Teresa; Ciudad, Juana; Such, Esperanza; Calasanz, María-José; Mercadal, Santiago; Coll, Rosa; González-Campos, José; Tormo, Mar; García-Cadenas, Irene; Gil, Cristina; Cervera, Marta; Barba, Pere; Costa, Dolors; Ayala, Rosa; Bermúdez, Arancha; Orfao, Alberto; Ribera, Josep-Maria

Ribera, Jordi; Granada, Isabel; Morgades, Mireia; González, Teresa; Ciudad, Juana; Such, Esperanza; Calasanz, María-José; Mercadal, Santiago; Coll, Rosa; González-Campos, José; Tormo, Mar; García-Cadenas, Irene; Gil, Cristina; Cervera, Marta; Barba, Pere; Costa, Dolors; Ayala, Rosa; Bermúdez, Arancha; Orfao, Alberto; Ribera, Josep-Maria.

Affiliation

Ribera J; Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Granada I; Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Morgades M; Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
González T; Hospital Universitario de Salamanca, Universidad de Salamanca, IBMCC (CSIC/USAL), IBSAL and CIBERONC, Salamanca, Spain.
Ciudad J; Cytometry Service (NUCLEUS) and Department of Medicine, Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), University of Salamanca, Salamanca, Spain.
Such E; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC) CB16/12/00400, Instituto de Salud Carlos III, Madrid, Spain.
Calasanz MJ; Hematology Department, Hospital Universitari Politècnic La Fe, Valencia, Spain.
Mercadal S; Centro de Investigación Clínica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain.
Coll R; Hematology Department, ICO-Hospital Duran i Reynals, Hospitalet de Llobregat, Spain.
González-Campos J; Hematology Department, ICO-Hospital Josep Trueta, Girona, Spain.
Tormo M; Hematology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
García-Cadenas I; Hematology Department, Hospital Clínico Universitario, Valencia, Spain.
Gil C; Hematology Department, Hospital de Sant Pau, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.
Cervera M; Hematology Department, Hospital General de Alicante, Alicante, Spain.
Barba P; Hematology Department, ICO-Hospital Joan XXIII, Tarragona, Spain.
Costa D; Hematology Department, Hospital Universitari Vall d'Hebrón, Barcelona, Spain.
Ayala R; Haematopathology Section, Department of Pathology, Hospital Clínic, Barcelona, Spain.
Bermúdez A; Hematology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.
Orfao A; Hematology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Ribera JM; Cytometry Service (NUCLEUS) and Department of Medicine, Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), University of Salamanca, Salamanca, Spain.

Br J Haematol ; 196(3): 670-675, 2022 02.

Article de En | MEDLINE | ID: mdl-34549416

Sujet(s)
Mots clés

acute lymphoblastic leukaemia; adults; cytogenetic alterations; prognosis; t(1;19)(q23;p13)/TCF3-PBX1

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Translocation génétique / Chromosomes humains de la paire 1 / Chromosomes humains de la paire 19 / Leucémie-lymphome lymphoblastique à précurseurs B / Protéines de fusion oncogènes / Maladie résiduelle Type d'étude: Diagnostic_studies / Prognostic_studies Aspects: Patient_preference Limites: Adolescent / Adult / Female / Humans / Male / Middle aged Langue: En Journal: Br J Haematol Année: 2022 Type de document: Article Pays d'affiliation: Espagne Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google